about
Presence of Air-Trapping and Mosaic Attenuation on Chest CT Predicts Survival in Chronic Hypersensitivity Pneumonitis.Outcome of critically ill patients with influenza virus infection.Derivation and diagnostic accuracy of the surgical lung injury prediction model.The practice of platelet transfusion in the intensive care unit.Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.Rheumatoid arthritis-interstitial lung disease-associated mortality.Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patientsAnti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia.Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.Sarcoidosis-related mortality in the United States from 1988 to 2007.Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease.A case of systemic malignant atrophic papulosis (Köhlmeier-Degos' disease).Sepsis during pregnancy.Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis.Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.FEV1 over time in patients with connective tissue disease-related bronchiolitis.High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival.Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease.Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitisTransfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study.Epidemiology of Hypersensitivity Pneumonitis among an Insured Population in the United States: A Claims-Based Cohort Analysis.Current Approach to Diagnosis and Management of Pulmonary Eosinophilic Syndromes: Eosinophilic Pneumonias, Eosinophilic Granulomatosis with Polyangiitis, and Hypereosinophilic Syndrome.Peeling away the layers of the volume-outcome effect and harvesting hidden connections.An educational initiative to improve the team-based care of patients with idiopathic pulmonary fibrosis.Clinical Predictors of a Diagnosis of Common Variable Immunodeficiency-related Granulomatous-Lymphocytic Interstitial Lung Disease.The addition of decision support into computerized physician order entry reduces red blood cell transfusion resource utilization in the intensive care unit.Nonfamilial hemophagocytic lymphohistiocytosis.US Trends in Mortality Rates for Primary Immunodeficiency DiseasesInhaled nitric oxide for acute right-ventricular dysfunction after extrapleural pneumonectomyMechanical ventilation in patients with Guillain-Barré syndromeAcute pancreatitis due to hereditary angioedemaIntraoperative tidal volume as a risk factor for respiratory failure after pneumonectomyA case of hydrocortisone desensitization in a patient with radiocontrast-induced anaphylactoid reaction and corticosteroid allergyEosinophilic lung diseasesInterpretation of airway pressure waveformsAir hunger, unwelcome guests, clogged pipes and idiopathic inflammatory myositis: can we do better?Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus StatementRefining the Burden of Idiopathic Pulmonary Fibrosis: The Cocktail Party EffectPamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
P50
Q30252395-35FBF4E0-86B9-4CC6-9CB8-61C8A3D91662Q30380019-0DC1D05F-0543-432D-82D6-2A521360BCDAQ30576043-388C740A-A01A-4461-A1B3-65C4740E9858Q33375078-7792E844-8BFD-4FC8-A746-EB71A0291ADCQ33577359-52A5E239-CBB7-4CCE-B77F-3C8403F33733Q33744934-49F75FDB-E030-41A0-B587-70913CA80781Q33776826-A1EDAABD-9543-4C6F-8B2D-00949D1C12DBQ33801027-B45BB3C3-14FB-4873-A41C-4F92C891DD75Q34118274-D2D326A2-6A3C-4332-8E13-F38E0B41E5EFQ35107684-E7ABDD68-2636-47A1-AF9A-F7CB4A4A94ACQ35497307-C918D0C0-7708-49FD-BB7E-8FB53C09E452Q35993864-427ACC89-CE56-485D-8A36-B97392F6ED07Q36075525-C04E6539-340E-476A-85E2-57A911A3DC28Q36281938-B1242FA7-9E15-4AB9-94E9-03EB9E2FB951Q36411185-353DA122-DF8E-4472-9EDF-713A36872699Q36913821-8035BFF3-F6B9-4528-B3EC-2373F3621FFDQ36969005-6DD4CCFD-75A0-4F0F-B392-1A1C50D28BFBQ38828132-85DDAF58-7920-4082-B559-5941F728FF2FQ40300908-C8486223-67CF-47C0-8C6C-636569E191FFQ41513645-8B9B4495-B960-4275-8E7A-D13DD9949261Q45124666-6F92E6B3-41FD-492D-B3E2-1D3579EA2410Q47317737-EA3A18A4-CE98-4004-B6E1-0BA3F55CB9AAQ47426542-8C274338-E9A7-467B-BDF4-F4490095CDCDQ48625453-2FFB5DDC-9295-4142-BB8E-7FDB8FD4EC23Q50285091-5792E8E8-F999-490E-BF2F-69DD9AE5CF12Q50656752-D34CACD3-B5B0-4DF8-B104-9C127C1FA4D4Q50708371-FEF4D321-48EA-4184-AD50-B2DB04356E9BQ53468768-EB9712E7-05DD-48F9-94EC-D37E7411DDABQ57480260-53666F5A-1A1B-43E0-89B9-70F632DEF01AQ79147881-E69054DE-57A8-4DC9-B65A-4FCB25D84CB1Q79393021-83A76F45-26B8-4072-8269-23E6CE6CC6BEQ79429547-74F324F9-09A6-4B1D-B109-67B570BABFFBQ79816885-F3643A26-0B93-418F-9E98-E325F69BDB7BQ80125618-B7DCA1E4-77AD-4FDE-8946-1F408F29B91EQ82232069-6232F283-70D6-4BFE-BAED-E02C83E2BA4BQ82895048-5A125A08-615C-40FE-9AFD-8C80F8F65D2DQ83378772-143B6EB7-EB24-4F8C-BFC7-94DC1FA596FDQ87964065-43F150CA-2451-4C25-9B72-775A33892201Q88211235-9507FE00-263C-4008-9445-3956928F6ADCQ90423103-BF6BA47F-704A-43F5-9FE9-72EEFA522D6F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Evans R Fernández Pérez
@ast
Evans R Fernández Pérez
@en
Evans R Fernández Pérez
@es
Evans R Fernández Pérez
@nl
type
label
Evans R Fernández Pérez
@ast
Evans R Fernández Pérez
@en
Evans R Fernández Pérez
@es
Evans R Fernández Pérez
@nl
prefLabel
Evans R Fernández Pérez
@ast
Evans R Fernández Pérez
@en
Evans R Fernández Pérez
@es
Evans R Fernández Pérez
@nl
P106
P31
P496
0000-0001-7535-1591